Evaluation of Asymptomatic Fasting Hypoglycemia in Outpatients Without Diabetes

References

1. 1.↵
   1. Melmed S,
   2. Auchus RJ,
   3. Goldfine AB,
   4. Koenig RJ,
   5. Rosen CJ

   1. Cryer PE,
   2. Arbelaez M. Hypoglycemia

   . In: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ, eds. Williams Textbook of Endocrinology. 14th ed. Philadelphia: Elsevier; 2020:1525–51.
2. 2.↵
   1. Nirantharakumar K,
   2. Marshall T,
   3. Hodson J,
   4. et al

   . Hypoglycemia in non-diabetic in-patients: clinical or criminal? PLoS One 2012;7:e40384.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Khanimov I,
   2. Shimonov M,
   3. Wainstein J,
   4. Leibovitz E

   . Hypoglycemia, malnutrition and body composition. Adv Exp Med Biol 2021;130:71–84.

   OpenUrl
4. 4.↵
   1. Cryer PE,
   2. Axelrod L,
   3. Grossman AB

   , Endocrine Societyet al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009;94:709–28.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Murad MH,
   2. Coto-Yglesias F,
   3. Wang AT,
   4. et al

   . Clinical review: drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 2009;94:741–5.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Marks V,
   2. Teale JD

   . Drug-induced hypoglycemia. Endocrinol Metab Clin North Am 1999;28:555–77.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Burke CW

   . Adrenocortical insufficiency. Clin Endocrinol Metab 1985;14:947–76.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Pia A,
   2. Piovesan A,
   3. Tassone F,
   4. et al

   . A rare case of adulthood-onset growth hormone deficiency presenting as sporadic, symptomatic hypoglycemia. J Endocrinol Invest 2004;27:1060–4.

   OpenUrlPubMed
9. 9.↵
   1. Placzkowski KA,
   2. Vella A,
   3. Thompson GB,
   4. et al

   . Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 2009;94:1069–73.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Svensson E,
    2. Muth A,
    3. Hedenström P,
    4. Ragnarsson O

    . The incidence of insulinoma in Western Sweden between 2002 and 2019. Ann Gastroenterol 2022;35:434–40.

    OpenUrlPubMed
11. 11.↵
    1. Service FJ,
    2. McMahon MM,
    3. O'Brien PC,
    4. Ballard DJ

    . Functioning insulinoma–incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991;66:711–9.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Hofeldt FD

    . Reactive hypoglycemia. Endocrinol Metab Clin North Am 1989;18:185–201.

    OpenUrlPubMed
13. 13.↵
    American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: standards of care in diabetes–2024. Diabetes Care 2024;47:S111–S125.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. González-Vidal T,
    2. Delgado E,
    3. Menéndez-Torre EW.

    Of Whipple’s triad. J Clin Pract Res 2023;45:655–7.

    OpenUrl
15. 15.↵
    1. Gude F,
    2. Díaz-Vidal P,
    3. Rúa-Pérez C,
    4. et al

    . Glycemic variability and its association with demographics and lifestyles in a general adult population. J Diabetes Sci Technol 2017;11:780–90.

    OpenUrlPubMed
16. 16.
    1. Matabuena M,
    2. Pazos-Couselo M,
    3. Alonso-Sampedro M,
    4. et al

    . Reproducibility of continuous glucose monitoring results under real-life conditions in an adult population: a functional data analysis. Sci Rep 2023;13:13987.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Matabuena M,
    2. Petersen A,
    3. Vidal JC,
    4. Gude F

    . Glucodensities: a new representation of glucose profiles using distributional data analysis. Stat Methods Med Res 2021;30:1445–64.

    OpenUrlPubMed
18. 18.
    1. Marco A,
    2. Pazos-Couselo M,
    3. Moreno-Fernandez J,
    4. et al

    . Time above range for predicting the development of type 2 diabetes. Front Public Health 2022;10:1005513.

    OpenUrlPubMed
19. 19.
    1. González-Rodríguez M,
    2. Pazos-Couselo M,
    3. García-López JM,
    4. et al

    . Postprandial glycemic response in a non-diabetic adult population: the effect of nutrients is different between men and women. Nutr Metab (Lond) 2019;16:46.

    OpenUrlPubMed
20. 20.↵
    1. González-Vidal T,
    2. Calvo-Malvar M,
    3. Fernández-Merino C,
    4. et al

    . Divergent hypoglycemic and hyperglycemic responses to the components of evening meals. a general adult population study in individuals without diabetes (AEGIS study). Clin Nutr 2024;43:379–90.

    OpenUrl
21. 21.↵
    1. Jarvis PRE,
    2. Cardin JL,
    3. Nisevich-Bede PM,
    4. McCarter JP

    . Continuous glucose monitoring in a healthy population: understanding the post-prandial glycemic response in individuals without diabetes mellitus. Metabolism 2023;146:155640.

    OpenUrlPubMed
22. 22.↵
    1. Alende-Castro V,
    2. Alonso-Sampedro M,
    3. Vazquez-Temprano N,
    4. et al

    . Factors influencing erythrocyte sedimentation rate in adults: new evidence for an old test. Medicine (Baltimore) 2019;98:e16816.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Alende-Castro V,
    2. Alonso-Sampedro M,
    3. Fernández-Merino C,
    4. et al

    . C-reactive protein versus erythrocyte sedimentation rate: implications among patients with no known inflammatory conditions. J Am Board Fam Med 2021;34:974–83.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care 2024;47:S20–S42.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Gual A,
    2. Martos AR,
    3. Lligona A,
    4. Llopis JJ

    . Does the concept of a standard drink apply to viticultural societies? Alcohol Alcohol 1999;34:153–60.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Román-Viñas BL,
    2. Ribas-Barba L,
    3. Ngo J,
    4. Serra-Majem L

    . Validity of the International Physical Activity Questionnaire in the Catalan population (Spain). Gac Sanit 2013;27:254–7.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Mendes MA,
    2. da Silva I,
    3. Ramires V,
    4. et al

    . Metabolic equivalent of task (METs) thresholds as an indicator of physical activity intensity. PLoS One 2018;13:e0200701.

    OpenUrlPubMed
28. 28.↵
    1. Craig CL,
    2. Marshall AL,
    3. Sjöström M,
    4. et al

    . International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Hoelzel W,
    2. Weykamp C,
    3. Jeppsson JO

    , IFCC Working Group on HbA1c Standardizationet al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004;50:166–74.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Matthews DR,
    2. Hosker JP,
    3. Rudenski AS,
    4. Naylor BA,
    5. Treacher DF,
    6. Turner RC

    . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Freckmann G,
    2. Mende J,
    3. Pleus S,
    4. et al

    . Mean absolute relative difference of blood glucose monitoring systems and relationship to ISO 15197. J Diabetes Sci Technol 2022;16:1089–95.

    OpenUrlPubMed
32. 32.↵
    1. Kovatchev BP,
    2. Patek SD,
    3. Ortiz EA,
    4. Breton MD

    . Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther 2015;17:177–86.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Suh S,
    2. Kim JH

    . Glycemic variability: how do we measure it and why is it important? Diabetes Metab J 2015;39:273–82.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. DeVries JH

    . Glucose variability: where it is important and how to measure it. Diabetes 2013;62:1405–8.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Rawlings RA,
    2. Shi H,
    3. Yuan LH,
    4. Brehm W,
    5. Pop-Busui R,
    6. Nelson PW

    . Translating glucose variability metrics into the clinic via continuous glucose monitoring: a graphical user interface for diabetes evaluation (CGM-GUIDE©). Diabetes Technol Ther 2011;13:1241–8.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Wood SN

    . Generalized additive models: An introduction with R. 2nd ed. Chapman and Hall/CRC; 2017.
37. 37.↵
    1. Sullivan PW,
    2. Morrato EH,
    3. Ghushchyan V,
    4. Wyatt HR,
    5. Hill JO

    . Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005;28:1599–603.

    OpenUrlAbstract/FREE Full Text
38. 38.↵
    1. Nguyen NT,
    2. Nguyen XM,
    3. Lane J,
    4. Wang P

    . Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006. Obes Surg 2011;21:351–5.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Schindler TH,
    2. Cardenas J,
    3. Prior JO,
    4. et al

    . Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 2006;47:1188–95.

    OpenUrlFREE Full Text
40. 40.↵
    1. Torimoto K,
    2. Okada Y,
    3. Tanaka Y,
    4. et al

    . Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study. BMC Cancer 2019;19:174.

    OpenUrlPubMed
41. 41.↵
    1. Matheus ASM,
    2. Pascoal JBF,
    3. Cabizuca CA,
    4. et al

    . Flash glucose monitoring system in patients with type 1 diabetes in healthcare center in Brazil: real world data from a short-term prospective study. Arch Endocrinol Metab 2023;67:289–97.

    OpenUrlPubMed
42. 42.↵
    1. Buzzetti R,
    2. Bonadonna RC,
    3. Giaccari A,
    4. et al

    . Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis. Diabetes Obes Metab 2022;24:327–31.

    OpenUrlPubMed